Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

When three isn't a crowd: A digyny concept for treatment-resistant, near-triploid human cancers

  • Kristine Salmina
  • , Bogdan I. Gerashchenko
  • , Michael Hausmann
  • , Ninel M. Vainshelbaum
  • , Pawel Zayakin
  • , Juris Erenpreiss
  • , Talivaldis Freivalds
  • , Mark S. Cragg
  • , Jekaterina Erenpreisa*
  • *Šī darba korespondējošais autors
  • Latvian Biomedical Research and Study Centre
  • NASU - Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • Heidelberg University 
  • University of Latvia
  • Riga Stradins University
  • Clinic iVF-Riga
  • University of Southampton

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

16 Atsauces (Scopus)

Kopsavilkums

Near-triploid human tumors are frequently resistant to radio/chemotherapy through mechanisms that are unclear. We recently reported a tight association of male tumor triploidy with XXY karyotypes based on a meta-analysis of 15 tumor cohorts extracted from the Mitelman database. Here we provide a conceptual framework of the digyny-like origin of this karyotype based on the germline features of malignant tumors and adaptive capacity of digyny, which supports survival in adverse conditions. Studying how the recombinatorial reproduction via diploidy can be executed in primary cancer samples and HeLa cells after DNA damage, we report the first evidence that diploid and triploid cell sub-populations constitutively coexist and inter-change genomes via endoreduplicated polyploid cells generated through genotoxic challenge. We show that irradiated triploid HeLa cells can enter tripolar mitosis producing three diploid sub-subnuclei by segregation and pairwise fusions of whole genomes. Considering the upregulation of meiotic genes in tumors, we propose that the reconstructed diploid sub-cells can initiate pseudo-meiosis producing two “gametes” (diploid “maternal” and haploid “paternal”) followed by digynic-like reconstitution of a triploid stemline that returns to mitotic cycling. This process ensures tumor survival and growth by (1) DNA repair and genetic variation, (2) protection against recessive lethal mutations using the third genome.

OriģinālvalodaAngļu
Raksta numurs551
ŽurnālsGenes
Sējums10
Izdevuma numurs7
DOIs
Publikācijas statussPublicēts - jūl. 2019

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

OECD Zinātnes nozare

  • 3. Medicīnas un veselības zinātnes

Nospiedums

Uzziniet vairāk par pētniecības tēmām “When three isn't a crowd: A digyny concept for treatment-resistant, near-triploid human cancers”. Kopā tie veido unikālu nospiedumu.

Citēt šo